Literature DB >> 12133717

The path to personalized medicine.

Joanne M Meyer1, Geoffrey S Ginsburg.   

Abstract

Advances in personalized medicine, or the use of an individual's molecular profile to direct the practice of medicine, have been greatly enabled through human genome research. This research is leading to the identification of a range of molecular markers for predisposition testing, disease screening and prognostic assessment, as well as markers used to predict and monitor drug response. Successful personalized medicine research programs will not only require strategies for developing and validating biomarkers, but also coordinating these efforts with drug discovery and clinical development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133717     DOI: 10.1016/s1367-5931(02)00340-x

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  13 in total

1.  The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities research.

Authors:  M Chris Gibbons; Malcolm Brock; Anthony J Alberg; Thomas Glass; Thomas A LaVeist; Stephen Baylin; David Levine; C Earl Fox
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

2.  Personalised medicine: a critique on the future of health care.

Authors:  Jacqueline Savard
Journal:  J Bioeth Inq       Date:  2013-03-21       Impact factor: 1.352

Review 3.  Genomic medicine: genetic variation and its impact on the future of health care.

Authors:  Huntington F Willard; Misha Angrist; Geoffrey S Ginsburg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 4.  An argument for renewed focus on epidemiology for public health.

Authors:  Elizabeth T Rogawski; Christine L Gray; Charles Poole
Journal:  Ann Epidemiol       Date:  2016-08-31       Impact factor: 3.797

5.  Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.

Authors:  Mariam M AlHilli; Andrea Mariani; Jamie N Bakkum-Gamez; Sean C Dowdy; Amy L Weaver; Preema P Peethambaram; Gary L Keeney; William A Cliby; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2014-03-29       Impact factor: 5.482

Review 6.  Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate.

Authors:  Matteo Sofia; Mauro Maniscalco; Guglielmo de Laurentiis; Debora Paris; Dominique Melck; Andrea Motta
Journal:  J Biomed Biotechnol       Date:  2011-03-15

7.  Network based consensus gene signatures for biomarker discovery in breast cancer.

Authors:  Holger Fröhlich
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

8.  Metabolomics: moving towards personalized medicine.

Authors:  Eugenio Baraldi; Silvia Carraro; Giuseppe Giordano; Fabiano Reniero; Giorgio Perilongo; Franco Zacchello
Journal:  Ital J Pediatr       Date:  2009-10-23       Impact factor: 2.638

9.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

10.  Reliability and Validity Assessment of Mizaj Questionnaire: A Novel Self-report Scale in Iranian Traditional Medicine.

Authors:  Morteza Mojahedi; Mohsen Naseri; Reza Majdzadeh; Mansoor Keshavarz; Mohammad Ebadini; Esmaeil Nazem; Mohsen Saberi Isfeedvajani
Journal:  Iran Red Crescent Med J       Date:  2014-03-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.